Intelligent Investor

Cann Group Limited (ASX: CAN) - Announcements

- Current share price for CAN : $0.062

ASX company news and announcements for Cann Group Limited (CAN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cann Group Limited (CAN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cann Group Limited (CAN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cann Group Limited (CAN)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$27 Appendix 3H - Notification of cessation of securities 2 Feb 2023 9:18AM $0.190 $0.062 $0.062 fallen by 67.37%
$27 Application for quotation of securities - CAN 1 Feb 2023 5:08PM $0.190 $0.062 $0.062 fallen by 67.37%
$27 Quarterly Activities and Appendix 4C Cashflow Report 30 Jan 2023 9:26AM $0.190 $0.062 $0.062 fallen by 67.37%
$27 S3 Trial update 19 Jan 2023 9:12AM $0.205 $0.062 $0.062 fallen by 69.76%
$27 Appointment of new CEO 10 Jan 2023 8:26AM $0.205 $0.062 $0.062 fallen by 69.76%
$27 Cann Group agrees terms for the sale of Southern facility 23 Dec 2022 11:03AM $0.200 $0.062 $0.062 fallen by 69%
$27 Change of Director's Interest Notice 7 Dec 2022 10:54AM $0.225 $0.062 $0.062 fallen by 72.44%
$27 Application for quotation of securities - CAN 7 Dec 2022 10:38AM $0.220 $0.062 $0.062 fallen by 71.82%
$27 Results of Share Purchase Plan offer 5 Dec 2022 10:04AM $0.230 $0.062 $0.062 fallen by 73.04%
$27 Close of Share Purchase Plan offer 1 Dec 2022 8:16AM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Port Jackson Securities investor webinar presentation 25 Nov 2022 11:59AM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Port Jackson Securities webinar 23 Nov 2022 4:46PM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Final clinical trial participant completes study 21 Nov 2022 9:38AM $0.230 $0.062 $0.062 fallen by 73.04%
$27 Share Purchase Plan offer closing date extended 16 Nov 2022 7:05PM $0.230 $0.062 $0.062 fallen by 73.04%
$27 Cann Group and Haleon sign non-binding term sheet 7 Nov 2022 9:15AM $0.240 $0.062 $0.062 fallen by 74.17%
$27 Cann Group Limited Investor Webinar 3 Nov 2022 8:14AM $0.230 $0.062 $0.062 fallen by 73.04%
$27 Share Purchase Plan - offer opens 31 Oct 2022 9:40AM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Cleansing Statement - Share Purchase Plan 31 Oct 2022 8:09AM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Appendix 3H - Notification of Cessation of Securities 28 Oct 2022 2:22PM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Application for quotation of securities - CAN 28 Oct 2022 1:18PM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Amended Quarterly Activities Report 27 Oct 2022 3:49PM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Quarterly Activities and Appendix 4C Cashflow Report 27 Oct 2022 12:36PM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Initial Director's Interest Notice - Dr Julian Chick 26 Oct 2022 10:59AM $0.235 $0.062 $0.062 fallen by 73.62%
$27 Results of Annual General Meeting 25 Oct 2022 11:52AM $0.235 $0.062 $0.062 fallen by 73.62%
$27 AGM presentation slides 25 Oct 2022 9:44AM $0.270 $0.062 $0.062 fallen by 77.04%

101 - 125 of 532 results

Page 5 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.